# Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)

> **NCT02546154** · — · COMPLETED · sponsor: **Pharmacosmos UK Ltd** · enrollment: 359 (actual)

## Conditions studied

- Iron Deficiency Anaemia

## Interventions

- **DRUG:** 10% Iron Isomaltoside 1000

## Key facts

- **NCT ID:** NCT02546154
- **Lead sponsor:** Pharmacosmos UK Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-22
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2019-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02546154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02546154, "Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02546154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*